Abstract: A battery assembly includes a battery module stack in which at least one battery module is stacked and formed, a cover portion coupled to a side of the battery module stack, and a substrate portion coupled to an external surface of the cover portion, wherein the cover portion includes a cover member coupled to the battery module stack, and a protrusion member protruding in an outward direction from the cover member and in contact with an internal surface of the substrate portion, the substrate portion includes an overlapping region which is a region overlapping the protrusion member when viewed in the outward direction, a through-hole passing through the overlapping region in the outward direction is formed in the overlapping region, and a pad region having electrically conductive properties is formed in a region surrounding the through-hole in the substrate portion.

Abstract: The present invention relates to a benzothiazole or benzimidazole derivative, a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same as an active ingredient for prevention or treatment of SIRTUIN 7 protein-related diseases. With excellent inhibitory activity against SIRTUIN 7 protein the derivative can be used for preventing or treating SIRTUIN 7 protein-related diseases.

Abstract: A display device includes a substrate that includes a display area and a non-display area, a display element layer disposed on the display area of the substrate, an opposing substrate that faces the substrate and the display element layer, a sealing member disposed on the non-display area and that couples the substrate and the opposing substrate, and a filler disposed between the substrate and the opposing substrate. A thickness of the filler varies in the range of 60% to 400% of a thickness of the sealing member.

Abstract: A display apparatus according to a concept of the disclosure includes: a display panel configured to display an image in a front direction; a top chassis positioned in a front direction of the display panel; a bottom chassis positioned in a rear direction of the display panel; a rear cover covering a rear side of the bottom chassis; and a stand member being accommodatable in the rear cover and selectively coupled with a rear surface of the rear cover, wherein the rear cover includes an accommodating portion in which the stand member is accommodated and a coupling portion coupled with the stand member, and the stand member includes an inserting protrusion which is inserted into the accommodating portion and the coupling portion.

Abstract: The present invention relates to use of peptides as a therapeutic agent for bone disease and autoimmune disease and more particularly, to a peptide consisting of an amino acid sequence represented by Formula 1 of the present invention, and use of the peptide for treating bone disease including osteoporosis, inflammatory disease, or autoimmune diseases including rheumatoid arthritis.

Abstract: The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, reduce the secretion of inflammatory cytokine IL-6, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.

Abstract: The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.

Abstract: The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, reduce the secretion of inflammatory cytokine IL-6, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.

Abstract: The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.

Abstract: The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.

Abstract: The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, reduce the secretion of inflammatory cytokine IL-6, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.

Abstract: The present invention relates to a system and method of delivering network data and, more particularly, to a scalable event delivery system and method supporting flexibility. The scalable event delivery system supporting flexibility includes, among a common core module, a convenience core module, a scale core module, and an extension function module, each being a function module considering a property of each of event processing functions, an event delivery system module configured by combining two or more modules including at least the common core module on the basis of a specific event processing environment; and a processor performing the specific event processing by using the event delivery system module. The scalable event delivery system supporting flexibility further includes a network adaptation module and a protocol adaptation module.

Abstract: A system for searching in accordance with an embodiment of the present invention includes: one or more sub nodes configured to generate one or more sub bloom filters corresponding to one or more object identification information; and a representative node configured to generate a representative bloom filter by applying an orthogonal code to each of said sub bloom filters and aggregating the sub bloom filters having the orthogonal code applied thereto, wherein, when the representative node receives a search request, the representative node is configured to apply the orthogonal code to the representative bloom filter and to determine whether object identification information included in the search request is included in sets corresponding to the sub bloom filters by referring to the representative bloom filter having the orthogonal code applied thereto.

Abstract: A next-generation mobile communication network apparatus and method using link layer routing. The network apparatus uses an existing IP address as an identifier while using a link layer address as a locator, and utilizers a location server that manages mapping between the IP address and the link layer address, thereby providing mobility.

Abstract: Disclosed is a method and apparatus for the non-invasive selection of high-quality seeds, based on optical coherence tomography, by which pathogen-infected and pathogen-free seeds can be discriminated in a non-invasive manner. The apparatus is operated by the processes of scanning a seed of diagnostic interest in a non-invasive manner using an optical coherence tomographic unit; processing interference signals of the scanned tomographic images to produce tomographic image data of the seed of diagnostic interest; analyzing the tomographic image data; comparing the analyzed tomographic image data with preset reference tomographic image data; diagnosing the seed of diagnostic interest as a pathogen-infected or pathogen-free seed according to the comparison data; and selecting high-quality seeds according to the diagnosis data. It can screen high-quality seeds with rapidity, convenience, and accuracy at a low cost and is industrially applicable, making a great contribution to agricultural quarantine inspection.

Abstract: A system for searching in accordance with an embodiment of the present invention includes: one or more sub nodes configured to generate one or more sub bloom filters corresponding to one or more object identification information; and a representative node configured to generate a representative bloom filter by applying an orthogonal code to each of said sub bloom filters and aggregating the sub bloom filters having the orthogonal code applied thereto, wherein, when the representative node receives a search request, the representative node is configured to apply the orthogonal code to the representative bloom filter and to determine whether object identification information included in the search request is included in sets corresponding to the sub bloom filters by referring to the representative bloom filter having the orthogonal code applied thereto.

Abstract: A next-generation mobile communication network apparatus and method using link layer routing. The network apparatus uses an existing IP address as an identifier while using a link layer address as a locator, and utilizers a location server that manages mapping between the IP address and the link layer address, thereby providing mobility.

Abstract: The present invention relates to a non-invasive early diagnostic method and device that allows an early diagnosis of Marssonina blotch disease, which infects apple tree leaves, before the occurrence of lesions to enable early prevention of apple Marssonina blotch disease.

Abstract: A convergence network based on an identifier and a communication method using the same are provided. The convergence network based on the identifier includes an underlying network including a plurality of communication entities and an access router configured to separate IDs and locators of the communication entities; at least one domain network configured in an overlay form using the access router, and configured to have a different identifier based on a communication type or a service type; and a global name server GNS configured to register an identifier for identifying each of a communication entities and a domain network. The communication entities communicate over the at least one domain network using the identifier.

Abstract: Disclosed are a method and an apparatus for mapping a locator and an identifier of a host by using an administrative domain identifier. A method that allows an administration domain to map location information of an internal host located in the administration domain with an identifier of the internal host, includes: receiving an internal host location information registration message from the internal host, by an access router that the internal host accesses; receiving the location information registration message from the access router, by a registration server of the administrative domain; and extracting a locator of the access router from the location information registration message and mapping the locator with the internal host identifier, by the registration server.